Leptomeningeal amyloidosis: features of the clinical picture (clinical observation)

[1]  M. Gertz,et al.  Burden of hereditary transthyretin amyloidosis on quality of life , 2019, Muscle & nerve.

[2]  V. Rameev,et al.  Peripheral nervous system involvement in systemic amyloidosis , 2018, Neurology, Neuropsychiatry, Psychosomatics.

[3]  O. Vorobyeva,et al.  The transthyretin amyloidosis: mini review and description of three cases among members of the same family , 2018, Nephrology and dialysis.

[4]  K. Shah,et al.  Intracranial and systemic manifestations of familial leptomeningeal amyloidosis, as seen on CT and MRI , 2018, Radiology case reports.

[5]  W. Mason,et al.  Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation. , 2018, World neurosurgery.

[6]  L. Amass,et al.  Global epidemiology of transthyretin hereditary amyloid polyneuropathy: a systematic review , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[7]  Y. Sekijima.  Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  E. Cunningham,et al.  Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. , 2007, Ophthalmology.

[9]  T. Hirai,et al.  Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis , 2005, Neurology.

[10]  A. Koeppen,et al.  Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. , 1999, Archives of neurology.

[11]  R. J. Schneider,et al.  Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. , 1988, Archives of neurology.

[12]  H. Goren,et al.  Familial oculoleptomeningeal amyloidosis. , 1980, Brain : a journal of neurology.

[13]  A. Polyakov,et al.  Hereditary transthyretin amyloidosis , 2020, Neuromuscular Diseases.